Navigation Links
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
Date:8/29/2007

atives, our capital needs and expenditures, potential acquisitions and divestitures, our debt repayment strategy, our operational strategy, and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward- looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward- looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Inspire Announces Presentations at Two European Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
(Date:1/15/2014)... LAVAL, Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global ... http://www.reportlinker.com/p098415/Global-Cell/Tissue-Culture-Supplies-Industry.html This report analyzes ... US$ Million by the following Product Segments: Media, ...
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Temperature ... This report analyzes the worldwide ... by the following Product Segments: Digital Thermometers, Infrared ...
Cached Medicine Technology:Global Cell/Tissue Culture Supplies Industry 2Global Cell/Tissue Culture Supplies Industry 3Global Cell/Tissue Culture Supplies Industry 4Global Cell/Tissue Culture Supplies Industry 5Global Cell/Tissue Culture Supplies Industry 6Global Cell/Tissue Culture Supplies Industry 7Global Cell/Tissue Culture Supplies Industry 8Global Cell/Tissue Culture Supplies Industry 9Global Cell/Tissue Culture Supplies Industry 10Global Cell/Tissue Culture Supplies Industry 11Global Cell/Tissue Culture Supplies Industry 12Global Cell/Tissue Culture Supplies Industry 13Global Cell/Tissue Culture Supplies Industry 14Global Cell/Tissue Culture Supplies Industry 15Global Cell/Tissue Culture Supplies Industry 16Global Cell/Tissue Culture Supplies Industry 17Global Cell/Tissue Culture Supplies Industry 18Global Cell/Tissue Culture Supplies Industry 19Global Temperature Monitoring Devices Industry 2Global Temperature Monitoring Devices Industry 3Global Temperature Monitoring Devices Industry 4Global Temperature Monitoring Devices Industry 5Global Temperature Monitoring Devices Industry 6Global Temperature Monitoring Devices Industry 7Global Temperature Monitoring Devices Industry 8Global Temperature Monitoring Devices Industry 9Global Temperature Monitoring Devices Industry 10Global Temperature Monitoring Devices Industry 11Global Temperature Monitoring Devices Industry 12Global Temperature Monitoring Devices Industry 13Global Temperature Monitoring Devices Industry 14Global Temperature Monitoring Devices Industry 15Global Temperature Monitoring Devices Industry 16Global Temperature Monitoring Devices Industry 17Global Temperature Monitoring Devices Industry 18
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... researcher has found a relationship between motor skill deficiencies ... disorder in very young children. , The findings, ... direct relationship between motor skills and autism severity, indicate ... be included in treatment plans for young children with ... College of Public Health and Human Sciences. , ...
(Date:4/23/2014)... investigators may lead to greater availability and acceptability of ... use of fecal material from healthy donors to treat ... ( C. difficile ) bacteria. In their paper ... Diseases , the researchers report that use of prescreened ... as successful in curing recurrent C. difficile ...
(Date:4/23/2014)... Washington State University Spokane have developed a new ... nod off behind the wheel. , Their recently ... are more variable in drowsy driversand offers an ... video-based driver drowsiness detection systems. , Van Dongen"Video-based ... car is drifting out of its lane are ...
(Date:4/23/2014)... report that rats exposed to high-energy particles, simulating conditions ... show lapses in attention and slower reaction times, even ... ranges. , The cognitive impairments which affected a ... appear to be linked to protein changes in ... to hold true in humans, suggest it may be ...
Breaking Medicine News(10 mins):Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:WSU innovation improves drowsy driver detection 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3
... eating beef from cattle with mad cow disease may ... individuals, say researchers according to a recent study. ... variant form of Creutzfeldt-Jakob disease (vCJD), which has been ... bovine spongiform encephalopathy (BSE), can be transmitted through an ...
... of aspirin may reduce the risk of colon polyps, which ... women between 34 and 77 years old. The participants underwent ... years, nearly 1,400 of the women were diagnosed with adenoma, ... ,Results show participants who reported taking aspirin regularly were 25-percent ...
... there is a lot of confusion about what type of diet ... a low carbohydrate diet, a new study shows a low fat, ... the amount of food is not restricted. ,For the research, ... alone and in combination with exercise. They looked at body weight ...
... blood may predict the risk of heart attack or death ... new study. ,Researchers conducted a study to determine whether ... for death or non-fatal heart attack in patients with acute ... factor family and it acts as an instigator of hardening ...
... Periodontal disease is a chronic bacterial infection that affects ... research shows a blood test can not only reveal ... periodontal disease risk. ,Researchers from Japan studied ... blood tests that checked for 37 items, including cholesterol ...
... and one that causes excessive absence from work. Many doctors ... returning them to normal activity levels. But many people with ... ,A new study suggests people with low back pain ... was conducted among the employees of an airline company in ...
Cached Medicine News:
... The Bugbox-M incorporates all the familiar and proven ... interface with the Ruskinn gas mixing system.The gas ... - 20% in 0.1% increments), carbon dioxide (0% ... - 10% in 1% increments) components of the ...
The airlock allows anaerobic entry of large flasks, vessels, and up to 90 plates at a time....
The 500 plate capacity MG-500 has an airlock for ease of use and an additional 100 plate capacity. Refrigeration is also available for growth of psychrophilic organisms...
... the operating theatre is ready for all current ... Its modern design allows a quick, problem-free conversion ... components are connected securely and sturdily to MARS ... if there should ever be a problem in ...
Medicine Products: